Nicklas, A. P., Kramer, M. W., Serth, J., Hennenlotter, J., Hupe, M. C., Reimer, D. U., . . . von Klot, C. J. (2018). Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC). Adv Ther.
Citação norma ChicagoNicklas, André P., et al. "Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients With Non-Muscle-Invasive Bladder Cancer (NMIBC)." Adv Ther 2018.
Citação norma MLANicklas, André P., et al. "Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients With Non-Muscle-Invasive Bladder Cancer (NMIBC)." Adv Ther 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.